Hepcvel 400mg/100mg Tablet is a combination of Sofosbuvir 400mg and Velpatasvir 100mg used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
| Manufacturer | Cipla Ltd |
| Packing | 28 Tablets in 1 Strip |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Lenvatol 10mg Capsule contains Lenvatinib, a targeted anti-cancer medicine used for treating certain types of advanced or metastatic cancers including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Cipla Ltd |
| Packing | 10 Capsules in a Bottle |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Pirfenex 200 mg tablet contains Pirfenidone, a medication used to treat Idiopathic Pulmonary Fibrosis (IPF) – a progressive lung disease that causes scarring (fibrosis) of the lung tissue.
| Composition | Pirfenidone |
| Manufacturer | Cipla Ltd |
| Packing | 15 Tablets in 1 Strip |
| Prescribed For | Idiopathic Pulmonary Fibrosis |
| Expiry | December 2027 |
Tenvir-EM Tablet is a combination of Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg), used in the treatment and prevention of HIV-1 infection.
| Composition | Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg) |
| Manufacturer | Cipla Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tofajak 5 mg Tablet contains Tofacitinib, a Janus kinase (JAK) inhibitor used primarily to treat autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
| Composition | Tofacitinib |
| Manufacturer | Cipla Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Diarrhoea Headache High Blood Pressure |
| Expiry | December 2027 |
Xbira 250 mg and 500 mg tablets contain Abiraterone Acetate, a hormonal therapy used in the treatment of prostate cancer, particularly metastatic castration-resistant prostate cancer (mCRPC).
| Composition | Abiraterone Acetate |
| Manufacturer | Cipla Ltd |
| Packing | 120 Tablets in a Bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Xylutide 40mg Capsule contains Enzalutamide, a medication used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer.
| Composition | Enzalutamide |
| Manufacturer | Cipla Ltd |
| Packing | 4 Capsules in 1 Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Zecyte 250mg Tablet contains Abiraterone Acetate, a hormonal therapy used to treat metastatic castration-resistant prostate cancer (mCRPC).
| Composition | Abiraterone Acetate |
| Manufacturer | Cipla Ltd |
| Packing | 120 Tablets in a Bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Efavir 600 Tablet contains Efavirenz 600 mg, an antiretroviral medicine used in the treatment of HIV-1 infection. It works by blocking the reverse transcriptase enzyme, which the HIV virus needs to multiply.
| Composition | Efavirenz 600 mg |
| Manufacturer | Cipla Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV infection |
| Expiry | December 2027 |
Dasatrue 70 mg tablet contains dasatinib and is used to treat certain types of blood cancer, especially chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It helps stop the growth of abnormal white blood cells.
| Composition | Dasatinib |
| Manufacturer | Cipla Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Cipla Limited is a globally recognized Indian pharmaceutical company committed to making healthcare more accessible and affordable. Founded in 1935, Cipla has grown into one of the most respected names in the industry, known for its high-quality, life-saving medications across a broad range of therapeutic areas.
With a presence in over 80 countries, Cipla delivers trusted solutions in respiratory care, oncology, cardiology, antiretrovirals (HIV/AIDS), diabetes, and more. Its strong portfolio of over 1,500 products is backed by world-class R&D, cutting-edge manufacturing facilities, and a deep commitment to patient care.
